The ONS Podcast
“A side effect patients might experience is lymphedema. This is an increased buildup of lymphatic fluid in the tissues, either in the breast or in the arm and hand of the affected side. It’s quite problematic for women. They might feel self-conscious. It might feel uncomfortable that the arm feels like it’s throbbing or heavy. Clothing may not fit quite right. So we’re always on the lookout for lymphedema,” Maria Fenton-Kerimian, APRN, AOCNP®, nurse practitioner at Weill Cornell Medicine in New York, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice...
info_outlineThe ONS Podcast
“You want to try to act quickly and be able to know what the pathways are for appropriate escalating when a patient is having symptoms that are reflective of cytokine release syndrome (CRS) or neurotoxicity. These toxicities are very manageable and treatable when recognized early. To summarize, choosing the right patient, knowing the toxicity profile for each product, and acting early is really what helps to prevent severe outcomes with chimeric antigen receptor (CAR) T-cell therapy,” Maribel Pereiras, PharmD, BCPS, BCOP, clinical pharmacy specialist at the John Theurer Cancer Center at...
info_outlineThe ONS Podcast
“Our goal of precision oncology has been to shift to tailored therapies that can help to improve treatment efficacy and ultimately improve patient outcomes. Resistance biomarker testing can help the care team to detect these genomic changes that the tumor may have acquired during therapy that makes the cells resistant to therapy. This information can be extremely helpful when we’re talking about making choices about second-line or subsequent-line therapy,” ONS member Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP®, advanced practice RN at the University of Texas MD Anderson Cancer...
info_outlineThe ONS Podcast
“The disease is increasingly managed as a chronic condition rather than a diagnosis with an immediate terminal outcome. Particularly, with earlier and more effective and sustained treatment options, we can make this disease a very chronic, long-term, livable condition. I want to make sure that patients are aware that this is not a death sentence. This is something that patients can live with for the long term,” Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®,...
info_outlineThe ONS Podcast
“We print education sheets that we have, and we say, ‘Just ignore this part that says cancer. You’re getting this med but for a different indication.’ And then you have to really point out what our goals of care are. You’re using the information that, as oncology nurses, we like and love, but we’re having to cross it out and say, ‘Just read this portion and just do this here.’ And that can be challenging for the nurse and probably confusing for the patient,” ONS member Brandy Thornberry, RN, OCN®, outpatient infusion and VAD supervisor at Logan Health in Kalispell, MT,...
info_outlineThe ONS Podcast
“Because the premise of immune checkpoint blockade centers around elevating the immune function, we should always take a great deal of caution around those patients who have high immune risks. Those include patients with autoimmune disorders. That’s one of our biggest questions that we ask, usually every consult that we’re seeing with solid tumor. ‘Do you have any history of autoimmune disorders? Tell me a little bit more about it. Is it being treated? What are your symptoms like?’ And then also patients who have undergone organ transplants. Now, interestingly, this does include stem...
info_outlineThe ONS Podcast
“It’s important to clarify that most patients will experience and at least some side effects—and often several. So prevention really means reducing severity, complications, and long-term impact rather than avoiding side effects altogether. This process starts before radiation begins and continues throughout the treatment and includes dental evaluation, baseline swallowing assessments, and thorough patient education,” ONS member Astrid Amoresano, RN, OCN®, lead oncology nurse specialist at New York Proton Center in New York, NY, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager...
info_outlineThe ONS Podcast
“You also want to deal with patient preferences. We do want to get their disease under control. We want to make them live a long, good quality of life. But do they want to come to the clinic once a week? Is it a far distance? Is geography a problem? Do they prefer not taking oral chemotherapies at home? We have to think about what the patient’s preferences are to some degree and kind of incorporate that in our decision-making plan for treatments for relapsed and refractory myeloma,” Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University...
info_outlineThe ONS Podcast
“Radioimmunoconjugates work through a dual mechanism that combines immunologic targeting with localized radiation delivery. The monoclonal antibody components bind to specific tumor-associated antigens such as CD20, expressed on malignant B cells. Once found, the attached radioisotope delivers beta radiation directly to the tumor, causing DNA damage and cell death,” Sabrina Enoch, MSN, RN, OCN®, CNMT, NMTCB (CT), theranostics clinical specialist at Highlands Oncology in Rogers, AR, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a...
info_outlineThe ONS Podcast
“The United States does not have a national cancer registry. We have a bunch of state registries. Some of those registries do collaborate and share information, but the issue is the registries that do exist typically do not report cancer by occupation. So, we cannot get our arms around the potential work-relatedness of the health outcome given the current way the state registries collect information. What we’re trying to set up, is a way to make what is currently an invisible risk, visible,” ONS member Melissa McDiarmid, MD, MPH, DABT, professor of medicine and epidemiology and public...
info_outline“I think the reality is that we as humans are having a human experience, some of which is incredible and some of which is terrible. And to deny ourselves the opportunity to feel any of those emotions would be to deny our own human experience. And so processing feelings, and I think the bigger ones in particular, like grief, especially in the work that we do, it’s not only good to do, but it’s part of just what it means to, I think, be a human,” Ann Konkoly, MBA, MSN, APRN-CNM, chief executive officer of Authentic Koaching LLC and Kultivate Women’s Health LLC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about processing grief in a healthcare context.
Music Credit: “Fireflies and Stardust” by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation.
Learning outcome: Learners will report an increase in knowledge related to processing grief.
Episode Notes
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other ONS Podcast episodes. Find a full list of opportunities.
- Oncology Nursing Podcast episodes:
- ONS Voice articles:
- Writing Condolence Cards Supports Nurses as Well as Deceased Patients’ Families
- When Grief Goes Beyond Burnout, Organizations Must Intervene
- Peer Groups Offer a Safe Space for Oncology Nurses to Share Lived Experiences
- Critical Event Debriefings Can Reduce Oncology Nurses’ Risk of Compassion Fatigue and Burnout
- Moral Injury and Trauma in Nursing: What You’re Feeling Is More Than Compassion Fatigue, but You’re Not Alone
- Achieve a Healthy Work-Life Balance With These ONS Member-Tested Techniques
- Involve All Populations in the Nurse Well-Being Conversation
- Clinical Journal of Oncology Nursing articles:
- ONS Nurse Well-Being Learning Library
- ONS Huddle Card: Moral Resilience
- American Association of Colleges of Nursing: End-of-Life Nursing Education Consortium
- Nurses Living the Good Life podcast
- Tara Brach: RAIN (Recognize, Allow, Investigate, Nurture) Technique
- Books mentioned in this episode:
- Permission to Feel by Mark Brackett
- Atlas of the Heart by Brené Brown
- Take Back Your Brain by Kara Loewentheil
- Feelings Wheel
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From This Episode
“Processing is just what we do with these big feelings or these small feelings that come up and how we work through them. And it really depends on the individual and what coping tools and mechanisms that they use. But usually for a lot of people, what we see is that when there is some sort of feeling—like grief—that comes along, one of the most important things that we can do is just to, number one, acknowledge that we are having some sort of a feeling and to then subsequently name it.” TS 2:05
“The brain, usually the limbic system, is driven by these three main things that it wants you to do at all times: It wants you to seek pleasure—number one. Number two, it wants you to avoid pain. And number three, it wants you to conserve energy. … And so from an evolutionary standpoint, it totally makes sense that when faced with a feeling like grief, the limbic system drives us to say, ‘Let’s avoid all that pain, because that feels really heavy and hard, and it’s going to take a lot of energy.’ And so many of us from a purely, you know, as a human approach to things that cause pain, we usually turn away from them.” TS 17:18
“For those of us out there who find we’re somewhat ill equipped and our partners or our colleagues are saying, ‘Boy, what’s going on?’ and we don’t know, the next step is to say, ‘Well, wait a minute. Who can help me kind of figure this out?’ And I think whether it’s therapy, whether it’s a coach, whether it’s a trusted mentor or colleague that you could have a very honest conversation with, whether it’s your employee assistance program that provides you with some resources and support, there’s no right or wrong way to go about it.” TS 26:45
“We have good data to say just the act of naming a feeling can be so helpful, can decrease our symptoms of that emotion by about 50%, which is crazy. Just from naming it, just from acknowledging that there’s a vibration there in your body and then naming it as like, ‘Oh, that vibration, that feeling that I have in my body that equates to grief or shame or discouragement.’” TS 32:58
“Are you willing to train your brain to see it differently and to make it work for you, and to find a way that it can work for you, and that you can think differently and that you can change your mindset? Because if you can do that, if you can learn to allow your feelings to come up and process them like grief when they come, if you can observe what you do in certain situations and what you don’t do—if you are willing to do that, you could go anywhere and do anything.” TS 43:06